{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:14:17Z","timestamp":1789391657012,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold> As fall events and injuries have become a growing public health problem in older patients and the causes of falls are complex, there is an emerging need to identify the risk of drug-induced falls.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To mine and analyze the risk signals of drug-induced falls in older patients to provide evidence for drug safety. The FDA Adverse Event Reporting System was used to collect drug-induced fall events among older patients. Disproportionality analyses of odds ratio (ROR) and proportional reported ratio were performed to detect the adverse effects signal.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 208,849 reports (34,840 fall events and 1,898 drugs) were considered. The average age of the included patients was 76.95 \u00b1 7.60\u00a0years, and there were more females (64.47%) than males. A total of 258 drugs with positive signals were detected to be associated with drug-induced fall incidence in older patients. The neurological drugs (104, 44.1%) with the largest number of positive detected signals mainly included antipsychotics, antidepressants, antiparkinsonian drugs, central nervous system drugs, anticonvulsants and hypnotic sedatives. Other systems mainly included the circulatory system (25, 10.6%), digestive system (15, 6.4%), and motor system (12, 5.1%).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Many drugs were associated with a high risk of falls in older patients. The drug is one of the critical and preventable factors for fall control, and the risk level of drug-induced falls should be considered to optimize drug therapy in clinical practice.<\/jats:p>","DOI":"10.3389\/fphar.2022.1044744","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T15:20:51Z","timestamp":1669735251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database"],"prefix":"10.3389","volume":"13","author":[{"given":"Shuang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.maturitas.2013.02.009","article-title":"Risk factors for falls among older adults: A review of the literature","volume":"75","author":"Ambrose","year":"2013","journal-title":"Maturitas"},{"key":"B2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1447-0594.2012.00965.x","article-title":"Estimation of the risk factors for falls in the elderly: Can meta-analysis provide a valid answer?","volume":"13","author":"Bloch","year":"2013","journal-title":"Geriatr. Gerontol. Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0157753","DOI":"10.1371\/journal.pone.0157753","article-title":"OpenVigil FDA - inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications","volume":"11","author":"B\u00f6hm","year":"2016","journal-title":"PloS one"},{"key":"B4","doi-asserted-by":"publisher","first-page":"371.e1","DOI":"10.1016\/j.jamda.2017.12.013","article-title":"Fall-risk-increasing drugs: A systematic review and meta-analysis: I. Cardiovascular drugs","volume":"19","author":"de Vries","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e000108","DOI":"10.1161\/HCQ.0000000000000108","article-title":"Preventing and managing falls in adults with cardiovascular disease: A scientific statement from the American Heart association","volume":"15","author":"Denfeld","year":"2022","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1046\/j.1532-5415.2002.50352.x","article-title":"Falls and fear of falling: Which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention","volume":"50","author":"Friedman","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/aje\/kws554","article-title":"Association of injurious falls with disability outcomes and nursing home admissions in community-living older persons","volume":"178","author":"Gill","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"Cd007146","DOI":"10.1002\/14651858.CD007146.pub2","article-title":"Interventions for preventing falls in older people living in the community","volume":"2012","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/jgs.16369","article-title":"Use of fall risk-increasing drugs around a fall-related injury in older adults: A systematic review","volume":"68","author":"Hart","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0897-1897(95)80592-3","article-title":"Hospital falls: Development of a predictive model for clinical practice","volume":"8","author":"Hendrich","year":"1995","journal-title":"Appl. Nurs. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1136\/injuryprev-2019-043286","article-title":"The global burden of falls: Global, regional and national estimates of morbidity and mortality from the global burden of disease study 2017","volume":"26","author":"James","year":"2020","journal-title":"Inj. Prev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3390\/ijerph19042298","article-title":"Risk of fall-related injuries associated with antidepressant use in elderly patients: A nationwide matched cohort study","volume":"19","author":"Jung","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fpubh.2016.00250","article-title":"The role of pharmacists in preventing falls among America's older adults","volume":"4","author":"Karani","year":"2016","journal-title":"Front. public health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1447-0594.2011.00703.x","article-title":"Association of polypharmacy with fall risk among geriatric outpatients","volume":"11","author":"Kojima","year":"2011","journal-title":"Geriatr. Gerontol. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1525-1497.2005.40171.x","article-title":"A case-control study of patient, medication, and care-related risk factors for inpatient falls","volume":"20","author":"Krauss","year":"2005","journal-title":"J. Gen. Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/epi.13600","article-title":"Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double-blind studies","volume":"58","author":"Leppik","year":"2017","journal-title":"Epilepsia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3760\/cma.j.cn112338-20200424-00646","article-title":"Analysis on epidemiologic characteristics of fall in old people: Results from Chinese national injury surveillance system, 2015-2018","volume":"42","author":"Lu","year":"2021","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40264-015-0351-3","article-title":"An empirical approach to explore the relationship between measures of disproportionate reporting and relative risks from analytical studies","volume":"39","author":"Maci\u00e1-Mart\u00ednez","year":"2016","journal-title":"Drug Saf."},{"key":"B19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1715163517690744","article-title":"Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: A systematic review","volume":"150","author":"Maximos","year":"2017","journal-title":"Can. Pharm. J. CPJ = Revue des Pharm. du Can. RPC"},{"key":"B20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jbspin.2006.09.002","article-title":"Pharmacovigilance for evaluating adverse drug reactions: Value, organization, and methods","volume":"73","author":"Montastruc","year":"2006","journal-title":"Jt. bone spine"},{"key":"B21","first-page":"366","volume":"8","author":"Morse","year":"1989","journal-title":"Dev. a Scale Identify Fall-Prone Patient"},{"key":"B22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.15171\/ijhpm.2019.11","article-title":"Risk factors for falls in hospital in-patients: A prospective nested case control study","volume":"8","author":"Najafpour","year":"2019","journal-title":"Int. J. Health Policy Manag."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bmj.315.7115.1049","article-title":"Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: Case-control and cohort studies","volume":"315","author":"Oliver","year":"1997","journal-title":"BMJ Clin. Res. ed)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101599","DOI":"10.1016\/j.arr.2022.101599","article-title":"Fall risk-increasing drugs and gait performance in community-dwelling older adults: A systematic review","volume":"77","author":"Osman","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40520-017-0749-0","article-title":"Tools for assessing fall risk in the elderly: A systematic review and meta-analysis","volume":"30","author":"Park","year":"2018","journal-title":"Aging Clin. Exp. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1574886315666200908110058","article-title":"Increased risk of falls, fall-related injuries and fractures in people with type 1 and type 2 diabetes - a nationwide cohort study","volume":"16","author":"Rasmussen","year":"2021","journal-title":"Curr. Drug Saf."},{"key":"B27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"372.e1","DOI":"10.1016\/j.jamda.2017.12.099","article-title":"Fall-risk-increasing drugs: A systematic review and meta-analysis: III. Others","volume":"19","author":"Seppala","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","article-title":"Fall-risk-increasing drugs: A systematic review and meta-analysis: II. Psychotropics","volume":"19","author":"Seppala","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/pds.5201","article-title":"Trends in fall-related mortality and fall risk increasing drugs among older individuals in the United States, 1999-2017","volume":"30","author":"Shaver","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.arr.2010.07.002","article-title":"Falls in aged people of the Chinese mainland: Epidemiology, risk factors and clinical strategies","volume":"9","author":"Wang","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4140\/TCP.n.2016.385","article-title":"Medication use, falls, and fall-related worry in older adults in the United States","volume":"31","author":"Watanabe","year":"2016","journal-title":"Consult. Pharm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12877-021-02695-9","article-title":"Persistent polypharmacy and fall injury risk: The health, aging and Body composition study","volume":"21","author":"Xue","year":"2021","journal-title":"BMC Geriatr."},{"key":"B35","volume-title":"A global report on falls prevention: Epidemiology of falls","author":"Yoshida","year":"2007"},{"key":"B36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00325481.2014.996112","article-title":"Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk","volume":"127","author":"Zia","year":"2015","journal-title":"Postgrad. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.22540\/JFSF-07-081","article-title":"The prevalence of polypharmacy and fall-risk-increasing drugs after hospital discharge for hip fracture: A retrospective study","volume":"7","author":"Zidrou","year":"2022","journal-title":"J. Frailty Sarcopenia Falls"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1044744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T15:20:57Z","timestamp":1669735257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1044744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":37,"alternative-id":["10.3389\/fphar.2022.1044744"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1044744","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"article-number":"1044744"}}